Related Experiment Video
Updated: May 29, 2026

11:03
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
A current update on the evolution of robotic liver surgery
K Kitisin1, V Packiam, D L Bartlett
1Division of Surgical Oncology, Department of Surgery, University of Pittsburgh Medical CenterPittsburgh, PA 15213, USA.
Minerva Chirurgica
|August 30, 2011
Summary
Robotic-assisted laparoscopic liver surgery is a safe and feasible minimally invasive option for resecting liver lesions. Further research is needed to confirm long-term benefits and oncologic outcomes.
Area of Science:
- Minimally Invasive Surgery
- Hepatobiliary Surgery
- Surgical Robotics
Background:
- Laparoscopic liver surgery has advanced, expanding minimally invasive options.
- Robotic technology addresses limitations of conventional laparoscopic liver resection.
- Complex liver surgeries are increasingly performed using robotic assistance.
Purpose of the Study:
- To comprehensively review the literature on robotic-assisted laparoscopic technology in liver surgery.
- To analyze patient series and outcomes of robotic liver resections.
- To evaluate the role and feasibility of robotic approaches in liver surgery.
Main Methods:
- PubMed literature search for English publications on robotic liver surgery.
- Selection of unique patient series for analysis.
- Review of outcomes including operative time, blood loss, length of stay, complications, conversion rates, cost, and oncologic results.
Main Results:
- Eight series with 134 unique patients were reviewed.
- Malignant lesions were resected in 69% of patients; benign in 31%.
- Common resections included segmentectomy/wedge (36%), left lateral sectionectomy (28%), right hepatectomy (16%), and left hepatectomy (9%).
Conclusions:
- Robotic liver surgery is a feasible and safe tool for minimally invasive resection of hepatic lesions.
- Outcomes varied widely across studies, precluding meta-analysis.
- Further evaluation is necessary to confirm outcome improvements and long-term oncologic results.